Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias

International Journal of Cardiology

Volumn 80, Issue 1, 2001, Pages 7-15

  Brembilla Perrot, B ^a   Houriez, P ^a   Beurrier, D ^a   Claudon, O ^a   Terrier De La Chaise, A ^a   Louis, P ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

Proarrhythmic effect; Signal averaged EGG

Indexed keywords

ANTIARRHYTHMIC AGENT; ATENOLOL; CIBENZOLINE; DIGOXIN; DISOPYRAMIDE; FLECAINIDE; PROPAFENONE; QUINIDINE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR CONDUCTION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG EFFECT; FEMALE; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM PACING; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HUMAN; MALE; P WAVE; PR INTERVAL; PREDICTION; PRIORITY JOURNAL; QRS COMPLEX; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SUPRAVENTRICULAR TACHYCARDIA;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; ATRIAL PREMATURE COMPLEXES; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; FORECASTING; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 0034878450     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(01)00459-4     Document Type: Article

References (25)

1. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs
2. The arrhythmogenicity of antiarrhyhmic agents
3. The proarrhythmic effects of antiarrhythmic drugs
4. Proarrhythmia: Definition, risk factors, causes, treatment and controversies
5. Preliminary report: Effect of encainide on normality in a randomized-trial of arrhythmia suppression after myocardial infarction
6. Atrial flutter: 1 to 1 conduction during treatment with quinidine and digitalis
7. Extreme tachycardia complicating the use of disopyramide in atrial flutter
8. Supraventricular tachycardia mimicing ventricular tachycardia during flecainide treatment
9. Atrial flutter in patient treatment for atrial fibrillation with propafenone
10. Possible atrial proarrhythmic effects of class Ic antiarrhythmic drugs
11. Regular ventricular rhythm in patients with symptomatic paroxysmal atrial fibrillation
12. Diagnostic value of ventricular stimulation in patient with idiopathic dilated cardiomyopathy
13. Significance and prevalence of inducible atrial tachyarrhythmias in patients undergoing electrophysiologic study for presyncope or syncope
14. Signal-averaged electrocardiogram after myocardial infarction: Correlation with the type of arrhythmias induced during electrophysiological study
15. P-wave signal averaging. High tech or an expensive alternative to the standard ECG?
16. P wave signal-averaged electrocardiography techniques
17. Effects of N-acetyl procainamide and recainam in the pharmacologic conversion and suppression of experimental canine atrial flutter: Significance of change in refractoriness
18. Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods
19. Proarrhythmic effects of the new antiarrhythmic agent flecaine acetate
20. Atrial flutter and fibrillation
21. Validation of double spike electrograms as markers of conduction delay or block in atrial flutter
22. Non-invasive technique for detection of electrical activity during the P-R segment
23. Detection of patients at risk for paroxsysmal atrial fibrillation during sinus rhythm by P wave triggered signal-avenged electrocardiogram
24. Characteristics of frequent content of atrial signal-averaged electrocardiogram during sinus rhythm in patients with paroxysmal atrial fibrillation
25. Quantitative analysis of signal-averaged P waves idiopathic paroxysmal atrial fibrillation